Orfonyx Bio Ltd
14212968
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 04/07/2022
PROFESSOR OF NEUROSCIENCE, UNIVERSITY OF
IRISH · UNITED KINGDOM · Age 63
Also on 2 other boards
secretary · Since 28/07/2022
director · Since 20/10/2022
INVESTOR
BRITISH · UNITED KINGDOM · Age 55
Also on 4 other boards
director · Since 12/05/2023
PARTNER AT OXFORD SCIENCE ENTERPRISES
DUTCH · NETHERLANDS · Age 37
director · Since 12/05/2023
PRINCIPAL LICENSING & VENTURES MANAGER
FRENCH · UNITED KINGDOM · Age 53
Persons with Significant Control
Oxford Science Enterprises Plc
46, Woodstock Road, Oxford, OX2 6HT
Reg: 09093331 · Companies House · Corporate
Notified 20/10/2022
Former PSCs
Thomas Charles Roberts
Ceased 20/10/2022
Nenad Svrzikapa
Ceased 20/10/2022
Prof Matthew John Andrew Wood
Ceased 20/10/2022
CompanyRankvs 425+ SIC 72110 peers75
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£847k
Balance sheet strength
Cash
£494k
Cash in the bank
Net Current Assets
£640k
Working capital
Current Assets
£770k
Current Liabilities
£131k
Fixed Assets
£207k
Debtors
£276k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 5.90 | -£693k |
| 2024 | 8.42 | +£1.1M |
| 2023 | 4.44 | — |
Derived from filed accounts. Not audited figures.